Report
Chris Kallos, CFA
EUR 101.80 For Business Accounts Only

Brownfield momentum and solid pipeline underscore near-term growth prospects for Healthscope.

We reiterate our AUD 2.60 per share fair value estimate for narrow-moat Healthscope after a tour of its Northern Beaches Hospital, or NBH, site. Importantly, construction of the AUD 840 million project remains on track and on budget, mitigating two important concerns for the market. Management remains confident the site will be operational on Oct. 30, 2018, able to receive patients on day one from Manly Hospital and Mona Vale, as planned. Closure of these two existing facilities and transfer of ...
Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Chris Kallos, CFA

Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch